51 related articles for article (PubMed ID: 34196992)
1. CCT6A regulates cervical cancer cell glycolysis and proliferation under hypoxic conditions via the TCAB1/TERT.
Wang Y; Wang H
Gynecol Obstet Invest; 2024 Apr; ():. PubMed ID: 38657573
[TBL] [Abstract][Full Text] [Related]
2. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer.
Kim TJ; Choi JJ; Kim WY; Choi CH; Lee JW; Bae DS; Son DS; Kim J; Park BK; Ahn G; Cho EY; Kim BG
Cancer Sci; 2008 Jan; 99(1):31-8. PubMed ID: 17986283
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the chaperonin T-complex protein-1 ring complex in human health and disease: A proteostasis modulator and beyond.
Zeng C; Han S; Pan Y; Huang Z; Zhang B; Zhang B
Clin Transl Med; 2024 Feb; 14(2):e1592. PubMed ID: 38363102
[TBL] [Abstract][Full Text] [Related]
5. Construction of a prognostic model for lung adenocarcinoma based on heat shock protein-related genes and immune analysis.
Zhou W; Zeng W; Zheng D; Yang X; Qing Y; Zhou C; Liu X
Cell Stress Chaperones; 2023 Nov; 28(6):821-834. PubMed ID: 37691069
[TBL] [Abstract][Full Text] [Related]
6. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
Peng S; Yu J; Wang Y
Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
[TBL] [Abstract][Full Text] [Related]
7. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N; Chen Y; Wu J
Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
[TBL] [Abstract][Full Text] [Related]
8. Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma.
Menegatti J; Nakel J; Stepanov YK; Caban KM; Ludwig N; Nord R; Pfitzner T; Yazdani M; Vilimova M; Kehl T; Lenhof HP; Philipp SE; Meese E; Fröhlich T; Grässer FA; Hart M
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291816
[TBL] [Abstract][Full Text] [Related]
9. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.
Wang H; Wang X; Xu L; Lin Y; Zhang J
Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer.
Wang X; Ni M; Han D
Evid Based Complement Alternat Med; 2022; 2022():3660110. PubMed ID: 35845587
[TBL] [Abstract][Full Text] [Related]
11. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
Peng W; Li W; Zhang X; Cen W; Liu Y
J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
[TBL] [Abstract][Full Text] [Related]
12. The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges.
Belousov PV
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203677
[TBL] [Abstract][Full Text] [Related]
13. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
14. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
15. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
Cai Y; Wu D; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer: A meta and bioinformatics analysis.
Shi S; Ma HY; Zhang ZG
Pathol Res Pract; 2021 Nov; 227():153624. PubMed ID: 34571355
[TBL] [Abstract][Full Text] [Related]
17. Chaperonins in cancer: Expression, function, and migration in extracellular vesicles.
Macario AJL; Conway de Macario E
Semin Cancer Biol; 2022 Nov; 86(Pt 1):26-35. PubMed ID: 34087417
[TBL] [Abstract][Full Text] [Related]
18. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
